Benzofuran derivatives and their anti-tubercular, anti-bacterial activities.

Anti-bacterial Anti-mycobacterial Anti-tubercular Benzofuran Hybrid compounds Structure-activity relationship

Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Jan 2019
Historique:
received: 09 10 2018
revised: 03 11 2018
accepted: 09 11 2018
pubmed: 19 11 2018
medline: 5 2 2019
entrez: 19 11 2018
Statut: ppublish

Résumé

Benzofuran is a fundamental structural unit in a variety of biologically active natural products, and its derivatives display various biological properties. Some benzofuran derivatives possess unique anti-tubercular and anti-bacterial action mechanism, and exhibit excellent in vitro and in vivo activities against both drug-sensitive and drug-resistant pathogens. Moreover, several benzofuran derivatives have already used in clinics for the treatment of various diseases. Thus, benzofuran is a useful pharmacophore to develop new anti-tubercular and anti-bacterial drugs. This review covers the recent advances of benzofuran derivatives as potential anti-tubercular and anti-bacterial agents, and the structure-activity relationship is also discussed to pave the way for the further rational development of this kind of derivatives.

Identifiants

pubmed: 30448416
pii: S0223-5234(18)30983-8
doi: 10.1016/j.ejmech.2018.11.025
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antitubercular Agents 0
Benzofurans 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

266-276

Informations de copyright

Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Auteurs

Zhi Xu (Z)

College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian, PR China. Electronic address: chemorgchem@126.com.

Shijia Zhao (S)

Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials, Wuhan University of Science and Technology, Wuhan, PR China.

Zaosheng Lv (Z)

Key Laboratory of Hubei Province for Coal Conversion and New Carbon Materials, Wuhan University of Science and Technology, Wuhan, PR China.

Lianshun Feng (L)

College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian, PR China.

Yinling Wang (Y)

College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian, PR China.

Feng Zhang (F)

College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian, PR China.

Liuyang Bai (L)

College of Chemistry and Pharmaceutical Engineering, Huanghuai University, Zhumadian, PR China.

Jialun Deng (J)

Haiso Technology Co., Ltd., Wuhan, PR China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH